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Abstract
Background: Typically, electrodes for Deep Brain Stimulation (DBS) are used for chronic stimulation. However,
there are conditions where this therapy has to be discontinued. In such cases using the DBS electrodes as a tool
for thermo-lesioning (coagulation) could be used for an alternative treatment. The aim of this study was to
determine if it is possible to generate coagula with a predictable geometry and to define their dimensions as a
function of power and time in an in vitro model (egg white at room temperature). Furthermore, we tested if
repetitive (cumulative) coagulation has an impact on the overall form and size of the clot.
Findings: Coagulation-growth was achieved as a function of power and duration of coagulation; reproducible
well-formed thermocoagulations could be achieved. When using two adjacent electrodes a power range between
1.25 Watt and 2.00 Watt resulted in homogenous ovoid coagula. After two minutes of coagulation the clots
reached a maximum in size and further growth could not be achieved. It was also possible to increase the size of
a preformed clot by repetitive coagulation either by increasing the power level or the duration of the coagulation
process.
Conclusions: We could show that it is possible to obtain predictable coagula in-vitro when using DBS electrodes
for thermocoagulation even though they have not been developed for that specific purpose. However, until in-
vivo safety and efficacy of DBS electrodes for ablation purposes is properly assessed, only approved electrodes
should be used for brain ablation.
Background
Today Deep Brain Stimulation (DBS) is state-of-the-art
for treating various cases of movement disorders and it
has widely replaced conventional therapeutic lesioning
(thalamotomy, pallidotomy) [1]. The adaptability and
reversibility of DBS makes it superior to ablative proce-
dures. Tremor, rigidity, and dystonia can be efficiently
treated. However, there are conditions where the ther-
apy has to be discontinued. Complications such as infec-
tion or erosion, loss of effect, tolerance, pain or
discomfort and device failure can result in terminating
the DBS treatment [2]. Also financial limitations can be
a reason for terminating the DBS treatment [3]. To us it
seems feasible and practical to perform lesions using
DBS electrodes which are already at the right location.
However, it remained unclear whether these lesions are
predictable in size and geometry, a key factor for a safe
use of ablative procedures.
The aim of this study was to determine if it is possible
to generate coagula with a predictable geometry and to
define their dimensions as a function of power and time
in an in vitro model (egg white at room temperature).
Furthermore, we tested if repetitive coagulations could
lead to a predictable change of size and shape of a pre-
existent coagulum.
Methods
Our laboratory setup was similar to the ones described
in [4-6]. In a container filled with egg white we slowly
inserted the DBS probe. The slow insertion of the DBS
probes into the egg white, which we kept at room tem-
perature, prevented the formation of air bubbles leading
to optimised visibility. A thin copper plate on the inner
side of one of the flat walls of the container acted as
reference electrode for monopolar coagulations. Ther-
mocouples placed at a maximum distance of 1 mm next
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development (figure 1, table 1).
A 500 kHz radio frequency (RF) generator (Neuro
N50, Stockert GmbH) delivering the high frequency cur-
rent to the DBS electrodes was connected to a PC
through an analogue/digital converter.
The software EPWIN-N50 (Stockert GmbH) con-
trolled the ablation current and graphically displayed the
electrode impedance, current and voltage over time. The
ablation process was monitored using a digital video
camera. Subsequently taken screenshots allowed to mea-
sure the coagulum size at different stages of its growth.
To compare the mean and standard deviation values
of the coagulum growth we systematically increased the
coagulation power and duration. For repeatability each
combination of power and time was repeated five times
in separate samples. To investigate coagulum growth of
cumulative ablation, we performed a primary coagula-
tion and after a short cooling period different para-
meters were used for another coagulation process.
Pictures of the coagulum after standardized time points
allowed measuring the coagulum size (the diameters of
the probe and the lesion were measured in pixels in
each picture and as the diameter of the probe is known,
the size of the coagulum could be calculated).
Findings
For the quadripolar electrodes we examined all six
possible locations for bipolar ablation. However, only
when choosing two adjacent poles as active ablation
electrodes homogenous coagulation ovoids formed
(figure 2a). The origin of the resulting coagulations
was situated near the two adjacent active poles. Abla-
tion over distant poles resulted in two smaller single
coagula with the same shape and size as monopolar
coagulations (figure 2b).
Lesion size is as a function of power and duration.
Increasing power and/or lesioning time showed the
trend of resulting in larger coagula (figure 3 and 4). Pre-
dictable and reproducible results were obtained in the
power range between 1.25 Watt and 2.00 Watt over the
duration of a maximum of 120 seconds. With less
power than 1.25 Watt no well-formed thermocoagula-
tions could be obtained. Applying more than 2.00 Watt
resulted in vaporisation and it was not possible to
achieve homogenous coagula. The incremental increase
in coagulation depth changed over time (figure 4). After
two minutes of coagulation the clots reached a maxi-
mum size and further growth could not be achieved
(plateau). The resulting clots were homogeneous and
ovoid in shape.
Cumulative coagulation, in terms of increasing the size
of a preformed coagulum, could be achieved. However,
further coagulum growth could only be managed either
by coagulating longer or with more power. For example,
Figure 1 Setup of the experiment.
Table 1 Means and standard deviations of temperatures
reached in function of lesioning duration and power.
1.25 W 1.51 W 1.73 W 2.00 W
30 s 59.2 +/- 4.0°C 65.9 +/- 4.4°C 67.2 +/- 3.7°C 71.8 +/- 4.2°C
60 s 63.5 +/- 4.2°C 69.3 +/- 3.5°C 73.7 +/- 5.3°C 82.1 +/- 5.7°C
90 s 66.3 +/- 5.2°C 71.3 +/- 4.6°C 76.6 +/- 5.5°C 82.9 +/- 5.9°C
120 s 68.1 +/- 5.5°C 72.9 +/- 4.7°C 78.3 +/- 5.2°C 85.5 +/- 7.1°C
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could either be increased with 1.51 Watt over 60 sec-
onds or with 1.25 Watt over the duration of more than
60 seconds. Applying the same parameters as the pri-
mary clot has been formed with - in this example 1.25
Watt over 60 seconds - did not lead to an increase in
size. Table 2 summarizes the coagula’s sizes for different
power levels and coagulation durations.
Discussion
There are conditions where patients treated with
chronic stimulation discover long-term complications
such as infection or erosion, loss of effect, tolerance,
pain or discomfort. In these cases the therapy has to be
discontinued and alternatives have to be found.
We tested if it was possible to perform reproducible
lesions with the already implanted and well-located DBS
electrodes. We could show in our in-vitro egg white
experiments that DBS electrodes can be used to form
predictable, reproducible and homogeneous ovoid coa-
gula. Due to a limited number of coagulations, we could
only show the trend of their increase of size in function
of power and/or lesioning duration.
The incremental increase in coagulation size reached a
maximum after two minutes. We assume that various
non-linear parameters are causing this effect. Change of
electric properties due to increasing impedance caused
by continuous tissue damage could be one explanation.
Certain tissue properties, such as relative density and
electrical conductivity, also vary in different anatomical
Figure 2 Schematic illustration of lesion development. a) Only when choosing two adjacent poles as active ablation electrodes homogenous
coagulation ovoids formed. Ablation over distant poles resulted in two smaller single coagula with the same shape and size as monopolar
coagulations. b) The origin of the resulting coagulations was situated near the two adjacent active poles of the quadripolar electrodes.
Figure 3 Example of the development of a lesion obtained with 1.73 Watt over 120 seconds. Homogenous ovoid lesions increased in
size in function of lesioning duration.
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Their impact on lesion size and shape should be
observed by modern finite element methods. Although
it has been stated that lesions’ sizes obtained in egg
white models are correlating with those obtained in vivo
[6], a generalization of this method to neural tissue
could be limited. Thus, to fully understand the efficacy
and safety of using DBS electrodes for ablation pur-
poses, the comparison of in vitro, computational (FEM)
and in vivo experiments appear to be mandatory. At
this point in time it is important to mention that these
electrodes are not approved for ablation procedures and
only approved electrodes should be used for brain
ablation.
Next steps in our research are to use computational
prediction of thermo ablation procedures in homoge-
neous media and then in anatomically correct models of
the human anatomy. These predictions will include
non-linear tissues parameters and account for blood
flow. Using these novel techniques we hope to develop
ablation electrodes for various coagula shapes using
multiple electrodes and computer controlled ablation
parameters.
Conclusion
Using DBS electrodes it is possible to produce reprodu-
cible and homogeneous thermo-coagulations with pre-
dictable size and shape in egg white.
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